SAB Biotherapeutics Inc (SABS): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 24.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name SAB Biotherapeutics Inc
Mitarbeiter 86
Handelsplatz NASDAQ
Ticker Symbol SABS
IPO Datum 2021-02-09
Adresse 777 W 41st St., Miami Beach, FL, United States, 33140
Webseite https://www.sab.bio
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Samuel J. Reich | CEO & Director |
| 2 | Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director |
| 3 | Ms. Lucy To | Executive VP & CFO |
| 4 | Dr. Christoph Bausch M.B.A., Ph.D. | Executive VP & COO |
| 5 | Dr. Alexandra Kropotova M.B.A., M.D. | Executive VP & Chief Medical Officer |
| 6 | Ms. Cristi Barnett | Vice President of Investor Relations & Corporate Communications |
| 7 | Ms. Catherine DeRose | Vice President of Human Resources |
| 8 | Ms. Hua Wu Ph.D. | Senior Vice President of Product Development |
| 9 | Dr. Carlos N. Carillo M.Sc., Ph.D. | Senior Vice President of Regulatory Affairs |
| 10 | Ms. Angie Parizek | Senior Vice President of Clinical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vivo Capital, LLC | 14,94% | 40,08 Mio. USD |
| 2 | Caligan Partners LP | 10,42% | 27,97 Mio. USD |
| 3 | Perceptive Advisors LLC | 8,41% | 22,58 Mio. USD |
| 4 | COMMODORE CAPITAL LP | 5,76% | 15,45 Mio. USD |
| 5 | RA Capital Management, LLC | 5,76% | 15,45 Mio. USD |
| 6 | Balyasny Asset Management LLC | 4,92% | 13,20 Mio. USD |
| 7 | Adage Capital Partners Gp LLC | 4,45% | 11,95 Mio. USD |
| 8 | Millennium Management LLC | 3,97% | 10,65 Mio. USD |
| 9 | Woodline Partners LP | 3,73% | 10,01 Mio. USD |
| 10 | Vanguard Capital Management, LLC | 3,26% | 8,75 Mio. USD |
| 11 | Spruce Street Capital LP | 2,88% | 7,72 Mio. USD |
| 12 | Sessa Capital, L.P | 2,88% | 7,72 Mio. USD |
| 13 | Vanguard Group Inc | 2,42% | 6,48 Mio. USD |
| 14 | BOOTHBAY FUND MANAGEMENT, LLC | 1,94% | 5,20 Mio. USD |
| 15 | Ameriprise Financial Inc | 1,93% | 5,18 Mio. USD |
| 16 | Ensign Peak Advisors Inc | 1,80% | 4,83 Mio. USD |
| 17 | Soleus Capital Management, L.P. | 1,37% | 3,69 Mio. USD |
| 18 | Propel Bio Management LLC | 1,32% | 3,56 Mio. USD |
| 19 | Jefferies Financial Group Inc | 1,18% | 3,17 Mio. USD |
| 20 | Blackstone Inc | 1,12% | 3,02 Mio. USD |